SPDR S&P Pharmaceuticals ETF
XPH
XPH
80 hedge funds and large institutions have $172M invested in SPDR S&P Pharmaceuticals ETF in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 11 closing their positions.
Holders
80
Holders Change
+1
Holders Change %
+1.27%
% of All Funds
2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
23
Reduced
25
Closed
11
Calls
$491K
Puts
–
Net Calls
+$491K
Net Calls Change
-$354K
Top Buyers
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$10.5M |
| 2 |
TSS
2
Two Sigma Securities
New York
|
$1.07M |
| 3 |
3
Citigroup
New York
|
$2.68M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$0 |
| 5 |
5
Wells Fargo
San Francisco,
California
|
$2.63M |
